ABUS insider trading — Arbutus Biopharma Corp
No open-market insider purchases or sales were filed for Arbutus Biopharma Corp (ABUS) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent ABUS insider transactions
Every Form 4 filed by Arbutus Biopharma Corp officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Beardsley Robert A | Director | D · Disposition | Direct | 17,948 | $5.00 | $90K | Form 4 |
| Oct 1, 2026 | Nguyen Tuan | Chief Financial Officer | D · Disposition | Direct | 48,081 | $5.00 | $240K | Form 4 |
| Oct 1, 2026 | Androski Lindsay | President and CEO | D · Disposition | Direct | 24,655 | $5.00 | $123K | Form 4 |
| Oct 1, 2026 | Sawhney Roger | Director | D · Disposition | Direct | 17,142 | $5.00 | $86K | Form 4 |
| Sep 18, 2026 | Androski Lindsay | President and CEO | M · Option exercise | Direct | 126,864 | $3.30 | $418K | Form 4 |
| Sep 18, 2026 | Androski Lindsay | President and CEO | F · Tax withholding | Direct | 82,527 | $5.07 | $418K | Form 4 |
| Sep 18, 2026 | Beardsley Robert A | Director | M · Option exercise | Direct | 131,333 | $3.82 | $502K | Form 4 |
| Sep 18, 2026 | Beardsley Robert A | Director | F · Tax withholding | Direct | 99,057 | $5.07 | $502K | Form 4 |
| Sep 18, 2026 | Nguyen Tuan | Chief Financial Officer | M · Option exercise | Direct | 293,100 | $3.57 | $1.05M | Form 4 |
| Sep 18, 2026 | Nguyen Tuan | Chief Financial Officer | F · Tax withholding | Direct | 206,637 | $5.07 | $1.05M | Form 4 |
| Sep 18, 2026 | Sawhney Roger | Director | M · Option exercise | Direct | 131,333 | $3.88 | $510K | Form 4 |
| Sep 18, 2026 | Sawhney Roger | Director | F · Tax withholding | Direct | 100,508 | $5.07 | $510K | Form 4 |
ABUS insider trading FAQ
Are insiders buying ABUS stock?
Not on the open market. In the last 90 days, Arbutus Biopharma Corp insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ABUS?
No insider bought or sold on the open market in the last 90 days.
Where does ABUS insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.